Phosphate diabetes is a condition characterized by excessive phosphate loss through the urine due to reduced phosphate reabsorption in the kidneys. This leads to low phosphate levels in the blood (hypophosphatemia) without the expected decrease in urinary phosphate excretion.
Phosphate diabetes is termed "diabetes" because it involves an abnormal loss of a substance (in this case, phosphate) through the urine, similar to how diabetes mellitus involves excessive glucose loss through urine. The word "diabetes" originates from a Greek word meaning "to pass through," referring to the excessive urination seen in these conditions.
In phosphate diabetes, the kidneys fail to properly reabsorb phosphate, leading to its excessive excretion in the urine. This parallels how, in diabetes mellitus, the body fails to reabsorb glucose effectively, resulting in its loss through urine. Therefore, the term "diabetes" is used to highlight this abnormal loss of essential substances in both conditions.
Diagnosing phosphate diabetes involves measuring phosphate clearance, the maximal rate of tubular phosphate reabsorption (TmPO4), and the ratio of TmPO4 to the glomerular filtration rate (TmPO4/GFR). Here’s how each of these factors is assessed:
Phosphate Diabetes Associated with Tumors
Inherited Phosphate Diabetes
Phosphate Diabetes from Complex Kidney Disorders
Primary Hyperparathyroidism
Moderate Idiopathic Phosphate Diabetes in Adults
Reference: